Search - tctmd.com

Displaying 181 - 200 of 214

Sort: Relevancy | Date

News Conference News AHA 2018

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

Yael L. Maxwell

November 12, 2018

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

News Daily News

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Michael O'Riordan

October 19, 2018

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

Shelley Wood

August 27, 2018

News Daily News

AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy

Lucy Hicks

August 24, 2018

News Daily News

Class I Recall for Medtronic’s HeartWare HVAD System

Michael O'Riordan

June 04, 2018

News Daily News

Heart Transplants From Overdose Deaths Are Soaring, With Promising Results

Yael L. Maxwell

April 17, 2018

News Conference News ACC 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

Shelley Wood

March 16, 2018

News Daily News

FDA Grants HeartWare LVAD a Destination Therapy Indication

Todd Neale

September 28, 2017

News Daily News

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

Shelley Wood

September 21, 2017

News Daily News

Palliative Care Ups Quality of Life, Mental Health for HF Patients

Caitlin E. Cox

July 19, 2017

News Daily News

Cardiac Recovery Possible in Patients With Cardiomyopathy Related to Methamphetamine Abuse

Todd Neale

May 30, 2017

News Conference News

Mixed Results, With Some Promising Data, in Heart Failure Destination Therapy Trial

Todd Neale

April 07, 2017

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Daily News

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

Michael O'Riordan

October 18, 2016

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Conference News ESC 2016

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

Shelley Wood

August 28, 2016

News Daily News

FDA Warns of Class I Recall for HeartWare VAD Batteries

Michael O'Riordan

June 29, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

Advertisement

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

MITRA-FR: No Benefit of MitraClip in Functional MR

AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy

Class I Recall for Medtronic’s HeartWare HVAD System

Heart Transplants From Overdose Deaths Are Soaring, With Promising Results

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

FDA Grants HeartWare LVAD a Destination Therapy Indication

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

Palliative Care Ups Quality of Life, Mental Health for HF Patients

Cardiac Recovery Possible in Patients With Cardiomyopathy Related to Methamphetamine Abuse

Mixed Results, With Some Promising Data, in Heart Failure Destination Therapy Trial

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

FDA Warns of Class I Recall for HeartWare VAD Batteries

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content